Stay updated with breaking news from Multi Center Cohort Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
When the current recommended diagnostic algorithm was used in clinical practice, antibody testing was required in half of patients with suspected HIT.
The multi-center study led to several important findings, one of which being that history of biologic-use could be a factor of importance in secukinumab retention prediction.